Brief: IRLAB Q1 EBIT SEK -37.6 Million
08/05/2024 06:50
May 8 (Reuters) - IRLAB Q1 operating cash flow SEK -38.2 million. * Q1 EBIT SEK -37.6 million * Q1 adjusted EPS SEK -0.75
IRLAB A — IRLAB Therapeutics AB News Story
0.000.00%
Last trade - 00:00- SEK165.12m
- SEK155.10m
- SEK57.46m